MedPath
HSA Product

BIOFLOR CAPSULES 250MG

Product approved by Health Sciences Authority (SG)

Basic Information

BIOFLOR CAPSULES 250MG

CAPSULE

Regulatory Information

SIN14986P

April 8, 2016

Pharmacy Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XA07FA02

Company Information

BIOCODEX

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Active Ingredients

Detailed Information

Contraindications

**Contra-indications** - Hypersensitivity to one of the components - Allergy to yeasts - Patients experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain - Immunocompromised or hospitalized patients (due to serious illness or altered/weakened immune system e.g. AIDS, lymphoma, patient undergoing long-term corticosteroid treatment - Patients with central venous catheter

Indication Information

**INDICATIONS** Helps to reduce the risk of antibiotic-associated diarrhea in adults.

© Copyright 2025. All Rights Reserved by MedPath